Małgorzata Wójcik

Maria Curie-Skłodowska University
Country flagPoland

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (11)

Year:

2025

The use of diversified raw materials and various extractant types is justified because the varied chemical composition of extracts obtained via extraction determines their biological activity. Therefore, the objective of this study was (i) to characterize the chemical profile of two types of bearberry extracts (70% ethanolic and water) and (ii) to investigate the biological activity of the analyzed extracts through an assessment of their possible proapoptotic effects on glioma cell lines. The HPLC-UV analysis of individual compounds was performed for the determination of the phytochemical profile of the bearberry extracts, and their total phenolic content (TPC) and total flavonoid content (TFC) were determined spectrophotometrically. The induction of apoptosis, autophagy, and necrosis in anaplastic astrocytoma MOGGCCM and human glioblastoma LN229 cell lines were investigated. The results indicated that the ethanolic (Et) and aqueous (Aq) extracts had different chemical profiles. The TPC in the Et was ca. 60% higher than in the Aq. Similarly, the TFC and methylarbutin (mARB) concentrations were significantly higher in the Et. On the other hand, the concentration of hydroquinone (HQ) was ca. 70% and that of corilagin (COR) was ca. 100% higher in the Aq. In turn, the presence of ursolic acid (UA) and oleanolic acid (OA) was confirmed solely in the Et. In contrast to Aq, Et demonstrated high proapoptotic activity. At the concentration of 2 µL/mL, the level of apoptosis varied between 14.7% and 26% in the case of the MOGGCCM cells and between 12.3% and 33.3% in the case of the LN229 cell line. The knowledge and information obtained in this study indicate a need for further research on the anticancer effect of the studied bearberry phytochemicals on the MOGGCCM and LN229 cell lines and for the elucidation of their molecular anticancer mechanisms.

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (11)

Panayiotis Trigas

Agricultural University of Athens

GREECE
View details

Izabela Swiecicka

Bialystok University of Technology

POLAND
View details

Katarzyna Dos Santos Szewczyk

Medical University of Lublin

POLAND
View details

Jaco Vangronsveld

-

BELGIUM
View details

Ewa Oleńska

University of Białystok

POLAND
View details

Sofie Thijs

Hasselt University

BELGIUM
View details

Łukasz Sęczyk

University of Life Sciences in Lublin

POLAND
View details

Andrzej Plak

Maria Curie-Skłodowska University

POLAND
View details

Adrian Zając

Assistant Proffesor/PhD

Maria Curie-Skłodowska University

POLAND
View details

Sylwia Okoń

University of Life Sciences

POLAND
View details

Joanna Czarnecka

Maria Curie-Skłodowska University

POLAND
View details
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.